Perspective Therapeutics (CATX) Assets Average (2011 - 2026)
Perspective Therapeutics recorded quarterly Assets Average of $338.9 million in Q1 2026, up 20.64% quarter-over-quarter from $280.9 million in Q4 2025, and up 1.09% year-over-year from $335.2 million in Q1 2025.
Perspective Therapeutics' Assets Average history runs 15 years deep, the most recent figure standing at $338.9 million for Q1 2026.
- In Q1 2026, Assets Average rose 1.09% year-over-year to $338.9 million; the TTM figure through Mar 2026 stood at $338.9 million (up 1.09% YoY), while the FY2025 annual figure was $304.0 million, up 38.52% from the prior year.
- Assets Average came in at $338.9 million for Q1 2026 at Perspective Therapeutics, up from $280.9 million in the prior quarter.
- In the past five years, Assets Average ranged from a high of $388.5 million in Q3 2024 to a low of $60.3 million in Q4 2022.
- A 5-year average of $208.5 million and a median of $188.1 million in 2024 frame the typical range for Assets Average.
- Across the five-year window, Assets Average jumped 251.35% in 2024 and dropped 23.28% in 2025, its largest moves.
- Perspective Therapeutics' Assets Average stood at $60.3 million in 2022, then jumped by 72.77% to $104.2 million in 2023, then surged by 251.35% to $366.1 million in 2024, then retreated by 23.28% to $280.9 million in 2025, then climbed by 20.64% to $338.9 million in 2026.
- According to Business Quant data, Assets Average over the past three periods registered $338.9 million, $280.9 million, and $302.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 98.57 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 47.07 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 91.42 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 44.01 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 13.51 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 31.64 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 6.49 Bn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 37.02 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 10.66 Bn |
| 10 | Perspective Therapeutics | 380.23 Mn | 380.23 Mn | - | 338.87 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 338.87 Mn |
| Dec 31, 2025 | 280.90 Mn |
| Sep 30, 2025 | 302.78 Mn |
| Jun 30, 2025 | 320.04 Mn |
| Mar 31, 2025 | 335.23 Mn |
| Dec 31, 2024 | 366.13 Mn |
| Sep 30, 2024 | 388.54 Mn |
| Jun 30, 2024 | 332.10 Mn |
| Mar 31, 2024 | 188.09 Mn |
| Dec 31, 2023 | 104.20 Mn |
| Sep 30, 2023 | 115.33 Mn |
| Jun 30, 2023 | 123.90 Mn |
| Mar 31, 2023 | 92.87 Mn |
| Dec 31, 2022 | 60.31 Mn |
| Sep 30, 2022 | 63.49 Mn |
| Jun 30, 2022 | 65.28 Mn |
| Mar 31, 2022 | 66.68 Mn |
| Dec 31, 2021 | 67.98 Mn |
| Sep 30, 2021 | 69.56 Mn |
| Jun 30, 2021 | 70.85 Mn |
| Mar 31, 2021 | 43.40 Mn |
| Dec 31, 2020 | 11.77 Mn |
| Sep 30, 2020 | 8.36 Mn |
| Jun 30, 2020 | 8.83 Mn |
| Mar 31, 2020 | 8.95 Mn |
| Dec 31, 2019 | 9.53 Mn |
| Sep 30, 2019 | 9.77 Mn |
| Jun 30, 2019 | 10.00 Mn |
| Mar 31, 2019 | 11.25 Mn |
| Dec 31, 2018 | 12.63 Mn |
| Sep 30, 2018 | 10.40 Mn |
| Jun 30, 2018 | 7.89 Mn |
| Mar 31, 2018 | 8.85 Mn |
| Dec 31, 2017 | 10.08 Mn |
| Sep 30, 2017 | 11.53 Mn |
| Jun 30, 2017 | 13.11 Mn |
| Mar 31, 2017 | 14.46 Mn |
| Dec 31, 2016 | 15.84 Mn |
| Sep 30, 2016 | 17.39 Mn |
| Jun 30, 2016 | 18.95 Mn |
| Mar 31, 2016 | 20.27 Mn |
| Jun 30, 2014 | 26.87 Mn |
| Mar 31, 2014 | 17.69 Mn |
| Dec 31, 2013 | 8.76 Mn |
| Sep 30, 2013 | 8.20 Mn |
| Jun 30, 2013 | 7.47 Mn |
| Mar 31, 2013 | 8.30 Mn |
| Dec 31, 2012 | 9.19 Mn |
| Sep 30, 2012 | 8.58 Mn |
| Jun 30, 2012 | 7.55 Mn |
| Mar 31, 2012 | 8.02 Mn |
| Dec 31, 2011 | 7.73 Mn |
| Sep 30, 2011 | 7.45 Mn |